Treatments & Interventions
Coal tar extract
substance
Betamethasone benzoate
substance
Vitamin D>3<
substance
Colloid sulfur
substance
Cortisone
substance
Trimethylpsoralen
substance
Methoxsalen
substance
Sulfur
substance
Coal tar
substance
Betamethasone dipropionate
substance
Betamethasone
substance
Betamethasone acetate
substance
Betamethasone sodium phosphate
substance
Flumetasone
substance
Cod liver oil
substance
Cortisone acetate
substance
Salicylate
substance
Calcitriol
substance
Tazarotene
substance
Etretinate
substance
Clinical Trials
Recent Trials
Modifying PEST for Psoriatic Arthritis Screening
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Research Evidence
Peer-reviewed studies linked via MeSH term "Psoriases" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 9014002
- UMLS CUI
- C0033860
- Fully Specified Name
- Psoriasis (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 20
- Clinical Trials
- 145
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.